Skip to main content
. Author manuscript; available in PMC: 2021 Nov 19.
Published in final edited form as: Clin Cancer Res. 2008 Jun 1;14(11):3462–3469. doi: 10.1158/1078-0432.CCR-07-4740

Fig. 1.

Fig. 1.

Representative median plasma rhIL-18 concentration versus time profiles spanning the dose range, showing the similarity in systemic exposure over time, from day 1 of cycle 1 to day 1 of cycle 2 (group A) and from week 1 to week 4 (group B).